Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Cholangiocarcinoma

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Cholangiocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Djaker, N; Khan, M; Li, X; Liu, H; Marsich, E; Sacco, P; Spadavecchia, J1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Cholangiocarcinoma

ArticleYear
DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.
    International journal of nanomedicine, 2022, Volume: 17

    Topics: Animals; Chitosan; Cholangiocarcinoma; Contrast Media; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lactose; Meglumine; Metal Nanoparticles; Mice; Organometallic Compounds; Pancreatic Neoplasms; Polymers

2022